This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Tuesday's Small-Cap Winners & Losers

NeurogesX (NGSX) was one of the biggest winners in Tuesday's cheery small-cap session as the biopharmaceutical company surged nearly 21% on positive top-line clinical trial results.

The San Carlos, Calif., company said the late-phase study -- which tested its NGX-4010 pain relief patch for patients with postherpetic neuralgia (a complication of shingles) -- achieved the primary and all secondary endpoints . Shares of NeurogesX were up $1.49 to $8.60.

Elsewhere in the health care sector, Massachusetts-based GTC Biotherapeutics (GTCB) climbed 12.8% after the Food and Drug Administration granted fast track designation to the company's ATryn compound. ATryn is proposed to treat hereditary antithrombin deficiency patients at risk for developing thrombosis or thromboembolism (respectively, blood clots in deeply embedded veins or blood clot lodgment) during surgery or childbirth.

GTC can now also submit the associated Biologics License Application for ATryn on a rolling basis. Shares were trading at $1.17, up 15 cents.

Semiconductor-equipment maker Kulicke & Soffa Industries (KLIC), based in Fort Washington, Pa., boosted its fourth-quarter sales forecast by $14 million to roughly $226 million. That should top the average analyst forecast by $13 million, according to Thomson Financial. Shares ratcheted up 9.1% to $9.33.

Elsewhere, clean-energies company Hoku Scientific (HOKU) soared 17% to $10.71 after Piper Jaffray upped the stock rating to market perform from underperform.

In the red, however, were several names pressured by negative analyst calls.

PeopleSupport (PSPT), for instance, fell 7.9% after JMP Securities cut the outsourcer to market perform from market outperform, citing the threat that the Los Angeles-based outfit might lose contracts with Washington Mutual and EarthLink -- two of its biggest clients. Shares were down 99 cents at $11.59.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs